MiR-124 Acts as a Target for Alzheimer’s Disease by Regulating BACE1

Oncotarget - United States
doi 10.18632/oncotarget.23119
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

miR-15b Represses BACE1 Expression in Sporadic Alzheimer�s Disease

Oncotarget
Oncology
2017English

SRGAP1, a Crucial Target of miR-340 and miR-124, Functions as a Potential Oncogene in Gastric Tumorigenesis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

Obesity and Alzheimer’s Disease, Does the Obesity Paradox Really Exist? A Magnetic Resonance Imaging Study

Oncotarget
Oncology
2018English

Evaluation of BACE1 Silencing as a Therapy Against Alzheimer Disease: Implications for Lipid Metabolism and Inflammatory Response

English

Mitigating Alzheimer`s Disease by Natural Polyphenols : A Review

Current Alzheimer Research
Neurology
2019English

The Core Sequence of PIF Competes for Insulin/Amyloid β In Insulin Degrading Enzyme: Potential Treatment for Alzheimer’s Disease

Oncotarget
Oncology
2018English

Study of the Effect of miR-124 and the SOX9 Target Gene in Hirschsprung’s Disease

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Menopause Dan Alzheimer`s Disease

Saintika Medika
2017English

Basic Research for Alzheimer′s Disease Drugs

Folia Pharmacologica Japonica
Pharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy